Company news
Alamar Biosciences, Inc. (NASDAQ:ALMR) news
Alamar Biosciences, Inc. news releases on 6ix. Latest, Oct 5, 2026: Alamar Biosciences Names Former Grail CEO Bob Ragusa to Board of Directors and Expands…
Press releases & updates
Alamar Biosciences Names Former Grail CEO Bob Ragusa to Board of Directors and Expands Leadership Team
October 5, 2026
Lancet Neurology Study Using Alamar Biosciences’ Technology Reveals Divergent Biological Responses to Alzheimer’s Treatment
September 24, 2026
Alamar Biosciences to Participate in Morgan Stanley 24th Annual Global Healthcare Conference
September 1, 2026
Alamar Biosciences Reports Second Quarter 2026 Financial Results and Provides 2026 Revenue Guidance
August 10, 2026
Alamar Biosciences Launches NULISAseq™ Immune 340 Panel for Comprehensive Profiling of the Immune Proteome
July 28, 2026
Alamar Biosciences to Report Second Quarter 2026 Financial Results on August 10, 2026
July 14, 2026
Alamar Biosciences Partners with Leading Research Universities to Launch National Initiative Advancing Blood-Based Biomarkers for Neurodegenerative Diseases
July 12, 2026
Alamar Biosciences NULISA Data Featured in More Than 140 Scientific Presentations at AAIC 2026, Highlighting Advances in Blood-Based Alzheimer’s Biomarker Profiling
July 10, 2026
Alamar Biosciences Launches the First Multiplexed Blood-based Immunoassay for eMTBR-Tau, One of the Most Important Biomarkers in Alzheimer’s Disease Research
July 7, 2026
Alamar Biosciences Makes Home-Collected Fingerstick Samples Compatible with Ultra High-Sensitivity, Multiplex Proteomics
June 2, 2026
Alamar Biosciences Reports First Quarter 2026 Financial Results
May 8, 2026
Alamar Biosciences to Participate in BofA Securities 2026 Healthcare Conference
May 5, 2026
Alamar Biosciences to Report First Quarter 2026 Financial Results on May 8, 2026
April 30, 2026